GL1X · GenesisL1 explorer

MolNFT v2 · #144869 · protein

Bovine trypsin bound to potent inhibitor

6BFP: “Bovine trypsin bound to potent inhibitor”. X-ray diffraction at 1.292, 2 ligands (DJY, CA). MolNFT v2 #144869 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6BFP
Type
protein
Length
221 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.292
Source
Bos taurus
UniProt
P00760
Ligands
DJY, CA

Structure

x-ray diffraction · resolution 1.292 · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein221—P00760

Ligands and binding sites

  • DJY · 3-{2-[(4-carbamimidoylphenyl)carbamoyl]-4-ethenyl-5-methoxyphenyl}-6-[(cyclopropylmethyl) carbamoyl]pyridine-2-carboxylic acid · ligand · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6BFP · Bovine trypsin bound to potent inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • 1TNL · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain A against A, TM-score 1.00
  • 1TNJ · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain A against A, TM-score 1.00
  • 1TNG · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain A against A, TM-score 1.00
  • 1TNH · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain A against A, TM-score 1.00
  • 1TNK · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain A against A, TM-score 1.00
  • 1TNI · Prediction of novel serine protease inhibitors · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.